Depo-Provera and skeletal health: a survey of Florida obstetrics and gynecologist physicians

Fraser, 1981, A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate, Med J Aust, 1, 1, 10.5694/j.1326-5377.1981.tb135992.x Kaufmann, 1998, The decline in US teen pregnancy rates, 1990-1995, Pediatrics, 102, 1141, 10.1542/peds.102.5.1141 Clark, 2001, Magnitude and variability of sequential estradiol and progesterone concentrations in women using depot medroxyprogesterone acetate for contraception, Fertil Steril, 75, 871, 10.1016/S0015-0282(01)01748-4 Mishell, 1972, Estrogenic activity in women receiving an injectable progestogen for contraception, Am J Obstet Gynecol, 113, 372, 10.1016/0002-9378(72)90687-4 Clark, 2004, Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate, Fertil Steril, 82, 1580, 10.1016/j.fertnstert.2004.04.064 Cromer, 2004, Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls, J Adolesc Health, 35, 434, 10.1016/j.jadohealth.2004.07.005 Cundy, 1998, Spinal bone density in women using depot medroxyprogesterone contraception, Obstet Gynecol, 92, 569, 10.1016/S0029-7844(98)00270-1 Cundy, 1991, Bone density in women receiving depot medroxyprogesterone acetate for contraception, BMJ, 208, 13, 10.1136/bmj.303.6793.13 Kass-Wolff, 2001, Bone loss in adolescents using Depo-Provera, JSPN, 6, 21 Orr-Walker, 1998, The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women, Clin Endocrinol, 49, 615, 10.1046/j.1365-2265.1998.00582.x Petitti, 2000, Steroid hormone contraception and bone mineral density: a cross-sectional study in an international population, Obstet Gynecol, 95, 736, 10.1016/S0029-7844(00)00782-1 Scholes, 2002, Injectable hormone contraception and bone density: results from a prospective study, Epidemiology, 13, 581, 10.1097/00001648-200209000-00015 Tang, 1999, Long-term depot-medroxyprogesterone acetate and bone mineral density, Contraception, 59, 25, 10.1016/S0010-7824(98)00144-9 Banks, 2001, Overview of the relationship between use of progestin-only contraceptives and bone mineral density, BJOG, 108, 1214, 10.1016/S0306-5456(01)00296-0 Cundy, 1994, Recovery of bone density in women who stop using medroxyprogesterone acetate, BMJ, 308, 247, 10.1136/bmj.308.6923.247 Scholes, 2005, Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception, Arch Pediatr Adolesc Med, 159, 139, 10.1001/archpedi.159.2.139 Westhoff, 2003, Depot-medroxyprogesterone acetate injection (Depo-Provera): a highly effective contraceptive option with proven long-term safety, Contraception, 68, 75, 10.1016/S0010-7824(03)00136-7 Kalkwarf, 1995, Bone mineral loss during lactation and recovery after weaning, Obstet Gynecol, 86, 26, 10.1016/0029-7844(95)00083-4 Polatti, 1999, Bone mineral changes during and after lactation, Obstet Gynecol, 44, 110 Michaelsson, 2001, Influence of parity and lactation on hip fracture risk, Am J Epidemiol, 153, 1166, 10.1093/aje/153.12.1166 U.S. Food and Drug Administration Cundy, 2002, Menopausal bone loss in long-term users of depot medroxyprogesterone acetate contraception, Am J Obstet Gynecol, 186, 978, 10.1067/mob.2002.122420 Gbolade, 1998, Bone density in long term users of depot medroxyprogesterone acetate, Br J Obstet Gynaecol, 105, 790, 10.1111/j.1471-0528.1998.tb10211.x Rosenberg, 2007, Bone status after cessation of use of injectable progestin contraceptives, Contraception, 76, 425, 10.1016/j.contraception.2007.08.010 Kaunitz, 2008, Bone density recovery after depot medroxyprogesterone acetate injectable contraception use, Contraception, 77, 67, 10.1016/j.contraception.2007.10.005 Curtis, 2006, Progestogen-only contraception and bone mineral density: a systematic review, Contraception, 73, 470, 10.1016/j.contraception.2005.12.010 Leslie, 2006, Application of the 1994 WHO classification to populations other than postmenopausal Caucasian women: the 2005 ISCD Official Positions, J Clin Densitom, 9, 22, 10.1016/j.jocd.2006.05.004 Cromer, 2006, Depot medroxyprogesterone acetate and bone mineral density in adolescents — the black box warning: a position paper of the society of adolescent medicine, J Adolesc Health, 39, 296, 10.1016/j.jadohealth.2006.03.011 Kaunitz, 2005, Depo-Provera's black box: time to reconsider?, Contraception, 72, 165, 10.1016/j.contraception.2005.05.011 2006, ACOG practice bulletin. No. 73: Use of hormonal contraception in women with coexisting medical conditions, Obstet Gynecol, 107, 1453, 10.1097/00006250-200606000-00055 Mosher, 2004, Use of contraception and use of family planning services in the United States, 1982-2002, Adv Data, 350, 1 Cromer, 2005, Double-blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception, Am J Obstet Gynecol, 192, 42, 10.1016/j.ajog.2004.07.041 Cundy, 2003, A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetate, J Clin Endocrinol Metab, 88, 78, 10.1210/jc.2002-020874 Deal, 1997, Osteoporosis: prevention, diagnosis, and management, Am J Med, 102, 35S, 10.1016/S0002-9343(97)00415-4 Loud, 2006, Adolescent Bone Health, Arch Pediatr Adolesc Med, 160, 1026, 10.1001/archpedi.160.10.1026 2006 2006 Patlas, 1999, Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats, Teratology, 60, 68, 10.1002/(SICI)1096-9926(199908)60:2<68::AID-TERA10>3.0.CO;2-H World Health Organization